Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BIOLASE Inc    BIOL

Delayed Quote. Delayed  - 01/19 09:59:49 pm
1.51 USD   -2.45%
01/10 BIOLASE : Announces Management Change
01/10 BIOLASE, INC. ( : BIOL) Files An 8-K Regulation FD Disclosure
01/09 BIOLASE : Announces Management Change
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

BIOLASE Inc : BIOLASE Expects to Report Positive Cash Flow From Operations for Q4 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/22/2013 | 02:44pm CET
BIOLASE Expects to Continue to Generate Positive Cash Flow From Operations for 2013 Overall

IRVINE, CA -- (MARKETWIRE) -- 01/22/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that based on preliminary unaudited financial results, the Company expects to report that it generated positive cash flow from operations for Q4 2012.

"We are pleased with our preliminary unaudited financial results for Q4 2012. It is rewarding to see that our restructuring efforts over the past two years have enabled us to turn the Company around and that we are making significant progress toward achieving our financial goals," said Federico Pignatelli, Chairman and CEO. "The trends we are seeing in the adoption of dental lasers also give us confidence in achieving continued double-digit growth of our core dental franchise. Based on our current plans, we expect the Company will continue to generate positive cash flow from operations for the overall year ending December 31, 2013."

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 290 patented and patent-pending technologies designed to provide biological treatment and clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment and CAD/CAM systems. BIOLASE has sold more than 21,000 lasers.

Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolaseinc, Twitter at twitter.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.

For further information, please contact:
Lisa Wilson
In-Site Communications, Inc.
212-759-3929


distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BIOLASE INC
01/13 BIOLASE, INC : Change in Directors or Principal Officers (form 8-K)
01/10 BIOLASE : Announces Management Change
01/10 BIOLASE, INC. (NASDAQ : BIOL) Files An 8-K Regulation FD Disclosure
01/09 BIOLASE, INC : Regulation FD Disclosure, Financial Statements and Exhibits (form..
01/09 BIOLASE : Announces Management Change
01/06 BIOLASE, INC : Change in Directors or Principal Officers (form 8-K)
2016 BIOLASE, INC. (NASDAQ : BIOL) Files An 8-K Regulation FD Disclosure
2016 BIOLASE, INC : Regulation FD Disclosure, Financial Statements and Exhibits (form..
2016 INVESTOR INVESTIGATION OVER POTENTIA : Biol)
2016 BIOLASE, INC : Change in Directors or Principal Officers (form 8-K)
More news
Sector news : Advanced Medical Equipment & Technology - NEC
04:33p Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/09 BIOLASE finance chief bids resigns
2016 BIOLASE's (BIOL) CEO Harold Flynn on Q3 2016 Results - Earnings Call Transcri..
2016 Biolase misses by $0.02, beats on revenue
2016 Midday Gainers / Losers
2016 BIOLASE's (BIOL) CEO Harold Flynn on Q2 2016 Results - Earnings Call Transcri..
Advertisement
Financials ($)
More Financials
Chart BIOLASE INC
Duration : Period :
BIOLASE Inc Technical Analysis Chart | BIOL | US0909111082 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts 0
Average target price 2,00 $
Spread / Average Target 29%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Harold C. Flynn President, Chief Executive Officer & Director
Paul N. Clark Chairman
Richard R. Whipp Vice President-Operations
Dmitri Boutoussov Vice President-Research & Development
Frederic H. Moll Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOLASE INC10.57%105
THERMO FISHER SCIENTIF..2.52%57 144
DANAHER CORPORATION4.30%56 159
BOSTON SCIENTIFIC CORP..10.59%32 571
PHILIPS-2.19%28 060
INTUITIVE SURGICAL, IN..4.56%25 692
More Results